Where panel review is tied to a patient compensation fund, the scheme frequently caps provider liability with the fund covering excess amounts, which changes exposure analysis fundamentally. Understanding whether the state operates such a fund and what the provider-level cap is determines the defendant's actual exposure regardless of the verdict. Panel findings also affect settlement leverage substantially.